FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Drug Screening and Confirmation Using Two LC Columns and Identical LC-MS/MS Conditions into a Single, for Streamlined Forensic
Workflow (TN-1369)
This tech note summarizes a harmonized LC-MS/MS method for screening and confirmation of a large panel of 60 drugs and metabolites in urine that was validated to meet the new ANSI/ASB 121 Standard using two Phenomenex HPLC columns and the ToxBox forensic test kits. This more efficient workflow should reduce turnaround time and sample backlogs for drug analysis, compared to traditional immunoassay screening followed by GC-MS confirmation for medicolegal casework.
Drug Screening and Confirmation Using Two LC Columns and Identical LC-MS/MS Conditions into a Single, for Streamlined Forensic
Workflow (TN-1369)
This tech note summarizes a harmonized LC-MS/MS method for screening and confirmation of a large panel of 60 drugs and metabolites in urine that was validated to meet the new ANSI/ASB 121 Standard using two Phenomenex HPLC columns and the ToxBox forensic test kits. This more efficient workflow should reduce turnaround time and sample backlogs for drug analysis, compared to traditional immunoassay screening followed by GC-MS confirmation for medicolegal casework.
Drug Screening and Confirmation Using Two LC Columns and Identical LC-MS/MS Conditions into a Single, for Streamlined Forensic
Workflow (TN-1369)
This tech note summarizes a harmonized LC-MS/MS method for screening and confirmation of a large panel of 60 drugs and metabolites in urine that was validated to meet the new ANSI/ASB 121 Standard using two Phenomenex HPLC columns and the ToxBox forensic test kits. This more efficient workflow should reduce turnaround time and sample backlogs for drug analysis, compared to traditional immunoassay screening followed by GC-MS confirmation for medicolegal casework.